Elsevier

Progress in Cardiovascular Diseases

Volume 31, Issue 4, January–February 1989, Pages 249-280
Progress in Cardiovascular Diseases

The historical development, cellular electrophysiology and pharmacology of amiodarone

https://doi.org/10.1016/0033-0620(89)90033-9Get rights and content

First page preview

First page preview
Click to open first page preview

References (181)

  • NA Sharp et al.

    Influence of thyroid hormone levels on the electrical and mechanical properties of rabbit papillary muscle

    J Mol Cell Cardiol

    (1985)
  • BN Singh et al.

    Amiodarone and thyroid function: Clinical implications during antiarrhythmic therapy

    Am Heart J

    (1983)
  • KR Latham et al.

    Interaction of amiodarone and desethylamiodarone with solubilized nuclear thyroid hormone receptors

    J Am Coll Cardiol

    (1987)
  • SA Gross et al.

    Amiodarone-induced ultrastructural changes in the canine myocardial fibers

    Am Heart J

    (1986)
  • P Chatelain

    Modulation by amiodarone of membrane fluidity and Na+K+ ATPase activity in rat brain synaptosomes

    Biochem Biophys Res Commun

    (1985)
  • P Chatelain et al.

    Amiodarone-induced modifications of the phospholipid physical state. A fluorescence polarization study

    Biochem Pharmacol

    (1986)
  • J Broekhuysen et al.

    Action of amiodarone on guinea-pig heart sodium and potassium-activated adenosine triphosphatase

    Biochem Pharmacol

    (1972)
  • ND Mostow et al.

    Amiodarone: Correlation of serum concentration with suppression of complex ventricular ectopic activity

    Am J Cardiol

    (1984)
  • RJ Hariman et al.

    Effects of intravenous amiodarone in patients with inducible repetitive ventricular responses and ventricular tachycardia

    Am Heart J

    (1984)
  • AS Pickoff et al.

    Dose-dependent electrophysiologic effects of amiodarone in the immature canine heart

    Am J Cardiol

    (1983)
  • S Yabek et al.

    Electrophysiologic effects of amiodarone in canine adult and neonatal myocardial and Purkinje fibers

    J Am Coll Cardiol

    (1985)
  • K Nademanee et al.

    Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening arrhythmias

    Am Heart J

    (1982)
  • HL Waxman et al.

    Amiodarone for control of sustained ventricular tachyarrhythmias: Clinical and electrophysiological effects in 51 patients

    Am J Cardiol

    (1982)
  • M Shenasa et al.

    Effect of amiodarone on conduction and refractoriness of the His-Purkinje system in the human heart

    J Am Coll Cardiol

    (1984)
  • JJ Heger et al.

    Amiodarone: Clinical efficacy and electrophysiology during long term therapy for recurrent ventricular tachycardia or ventricular fibrillation

    N Engl J Med

    (1981)
  • K Nademanee et al.

    Anti-arrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening arrhythmias

    Am Heart J

    (1982)
  • K Nademanee et al.

    Control of refractory life-threatening ventricular arrhythmias by amiodarone

    Am Heart J

    (1981)
  • JJ Heger et al.

    Clinical use and pharmacology of amiodarone

    Med Clin North Am

    (1984)
  • K Nademanee et al.

    Amiodarone in refractory life-threatening ventricular arrhythmias

    Ann Intern Med

    (1983)
  • TB Graboys et al.

    Efficacy of amiodarone for refractory supraventricular tachyarrhythmias

    Am Heart J

    (1983)
  • DP Zipes et al.

    Amiodarone: Electrophysiologic actions pharmacokinetics and clinical effects

    J Am Coll Cardiol

    (1984)
  • MB Rosenbaum et al.

    Clinical efficacy of amiodarone as an antiarrhythmic agent

    Am J Cardiol

    (1976)
  • P Polster et al.

    The adrenergic antagonism of amiodarone

    Biochem Pharmacol

    (1976)
  • R Charlier et al.

    Pharmacology of amiodarone, an antianginal drug with a new biological profile

    Arzneimittelforschung

    (1968)
  • R Charlier et al.

    Récherche dans la série des benzofurannes. VII. Étude pharmacologique préliminaire du butyl-2(diiodo 3′5′-beta-N-diethylaminoethoxy-4′benzoyl)-3 benzofurannes

    Arch Int Pharmacodyn Ther

    (1962)
  • M Vastesaeger et al.

    Étude clinique d'une nouvelle medication anti-angoreuse

    Acta Cardiol(Brux)

    (1967)
  • R Charlier et al.

    Récherche dans la série des benzofurannes. XL. Proprieté anti-arrhythmiques de l'amiodarone

    Cardiologia

    (1969)
  • BN Singh et al.

    The effect of amiodarone, a new anti anginal drug, on cardiac muscle

    Br J Pharmacol

    (1970)
  • BN Singh

    A study of the pharmacological actions of certain drugs and hormones with a particular reference to cardiac muscle

  • BN Singh et al.

    A third class of antiarrhythmic action? Effects on atrial and ventricular intracellular potentials and other pharmacologic actions on cardiac muscle of MJ1999 and AH3474

    Br J Pharmacol

    (1970)
  • J Van Schepdael et al.

    Étude clinique de l'amiodarone dans les troubles du rhythme cardiaque

    Presse Med

    (1970)
  • MB Rosenbaum et al.

    Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride

    Am J Cardiol

    (1974)
  • DA Pritchard et al.

    Effects of amiodarone on thyroid function in patients with ischemic heart disease

    Br Heart J

    (1975)
  • A Burger et al.

    Effect of amiodarone on serum triiodothyronine, thyroxine and thyrotropin: A drug influencing peripheral metabolism of thyroid hormones

    J Clin Invest

    (1976)
  • AS Freedberg et al.

    The effects of altered thyroid state on atrial intracellular potentials

    J Physiol

    (1970)
  • R Charlier

    Cardiac actions in the dog of a new antagonist of adrenergic excitation which does not produce competitive blockade of adrenoceptors

    Br J Pharmacol

    (1970)
  • R Charlier et al.

    Opposite effects of amiodarone and beta-blocking agents on cardiac functions under adrenergic stimulation

    Arzneimittelforschung

    (1972)
  • M Kobayashi et al.

    Acute effects of amiodarone in the isolated dog heart

    Can J Physiol Pharmacol

    (1983)
  • Cited by (119)

    View all citing articles on Scopus

    Supported by grants from the Medical Research Service of the Veterans Administration and the American Heart Association, the Greater Los Angeles Affiliate, Los Angeles.

    View full text